OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
Fabrizio Martora, Matteo Megna, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 135-148
Open Access | Times Cited: 51
Fabrizio Martora, Matteo Megna, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 135-148
Open Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 159-166
Open Access | Times Cited: 23
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 159-166
Open Access | Times Cited: 23
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
Fabrizio Martora, Massimiliano Scalvenzi, Angelo Ruggiero, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 801-801
Open Access | Times Cited: 37
Fabrizio Martora, Massimiliano Scalvenzi, Angelo Ruggiero, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 801-801
Open Access | Times Cited: 37
Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm
Carlo Alberto Maronese, Chiara Moltrasio, Giovanni Genovese, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 5, pp. 525-545
Closed Access | Times Cited: 27
Carlo Alberto Maronese, Chiara Moltrasio, Giovanni Genovese, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 5, pp. 525-545
Closed Access | Times Cited: 27
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study
Teresa Battista, Lucia Gallo, Fabrizio Martora, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1940-1940
Open Access | Times Cited: 9
Teresa Battista, Lucia Gallo, Fabrizio Martora, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1940-1940
Open Access | Times Cited: 9
Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment
Yi-Lun Chu, Sebastian Yu
Biomedicines (2024) Vol. 12, Iss. 2, pp. 338-338
Open Access | Times Cited: 8
Yi-Lun Chu, Sebastian Yu
Biomedicines (2024) Vol. 12, Iss. 2, pp. 338-338
Open Access | Times Cited: 8
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments
Teresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1899-1932
Open Access | Times Cited: 16
Teresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1899-1932
Open Access | Times Cited: 16
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
Fabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2525-2536
Open Access | Times Cited: 15
Fabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2525-2536
Open Access | Times Cited: 15
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
Luca Potestio, Elisa Camela, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2045-2059
Open Access | Times Cited: 14
Luca Potestio, Elisa Camela, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2045-2059
Open Access | Times Cited: 14
Pyoderma gangrenosum and Behçet’s-like disease induced by secukinumab: a paradoxical drug reaction
Ceylan Avcı, Gülfem Akın, Sevgi Akarsu, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 13
Ceylan Avcı, Gülfem Akın, Sevgi Akarsu, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 13
Expert Practices in Hidradenitis Suppurativa Flare Management: A Cross-Sectional Survey Study
Rahul Masson, Sarah Park, Vivian Y. Shi, et al.
Skin Appendage Disorders (2024) Vol. 10, Iss. 3, pp. 224-228
Open Access | Times Cited: 5
Rahul Masson, Sarah Park, Vivian Y. Shi, et al.
Skin Appendage Disorders (2024) Vol. 10, Iss. 3, pp. 224-228
Open Access | Times Cited: 5
Beyond the skin: endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa
Anna Dattolo, Mónica Torres Sánchez, Evelyn Frías-Toral, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Anna Dattolo, Mónica Torres Sánchez, Evelyn Frías-Toral, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar
Sreethish Sasi, Hamad Abdel Hadi, Masautso Chaponda, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
Sreethish Sasi, Hamad Abdel Hadi, Masautso Chaponda, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
Secukinumab in the Treatment of Hidradenitis Suppurativa
Corey L. Snyder, Ruby S. Gibson, Martina L. Porter, et al.
Immunotherapy (2023) Vol. 15, Iss. 17, pp. 1449-1457
Closed Access | Times Cited: 10
Corey L. Snyder, Ruby S. Gibson, Martina L. Porter, et al.
Immunotherapy (2023) Vol. 15, Iss. 17, pp. 1449-1457
Closed Access | Times Cited: 10
Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female
Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, et al.
Dermatology Reports (2025)
Open Access
Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, et al.
Dermatology Reports (2025)
Open Access
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature
Fabrizio Martora, Nello Tommasino, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 617-626
Open Access
Fabrizio Martora, Nello Tommasino, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 617-626
Open Access
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on ‘Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab’
Fabrizio Martora, Gabriella Fabbrocini, Claudio Marasca, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 6, pp. 701-703
Closed Access | Times Cited: 9
Fabrizio Martora, Gabriella Fabbrocini, Claudio Marasca, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 6, pp. 701-703
Closed Access | Times Cited: 9
Investigating Adiposity-Related Metabolic Health Phenotypes in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study
Dillon Mintoff, Rachel Agius, Stephen Fava, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4847-4847
Open Access | Times Cited: 9
Dillon Mintoff, Rachel Agius, Stephen Fava, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4847-4847
Open Access | Times Cited: 9
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
Fabrizio Martora, Gabriella Fabbrocini, Matteo Megna, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1037-1037
Open Access | Times Cited: 8
Fabrizio Martora, Gabriella Fabbrocini, Matteo Megna, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1037-1037
Open Access | Times Cited: 8
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review
Jessica R. Allegretti, Jessica H. Brady, A.M. Wicker, et al.
Advances in Therapy (2024) Vol. 41, Iss. 5, pp. 1775-1794
Open Access | Times Cited: 3
Jessica R. Allegretti, Jessica H. Brady, A.M. Wicker, et al.
Advances in Therapy (2024) Vol. 41, Iss. 5, pp. 1775-1794
Open Access | Times Cited: 3
A Case of Dissecting Cellulitis of the Scalp, Hidradenitis Suppurativa, and Conglobate Acne Successfully Treated with Secukinumab
Natale Schettini, Elisa Marzola, Lucrezia Pacetti, et al.
Skin Appendage Disorders (2024) Vol. 10, Iss. 3, pp. 232-235
Closed Access | Times Cited: 2
Natale Schettini, Elisa Marzola, Lucrezia Pacetti, et al.
Skin Appendage Disorders (2024) Vol. 10, Iss. 3, pp. 232-235
Closed Access | Times Cited: 2
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature
Fabrizio Martora, Teresa Battista, Angelo Ruggiero, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 6
Fabrizio Martora, Teresa Battista, Angelo Ruggiero, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 6
Herpes Zoster and COVID-19 Vaccination: A Narrative Review
Luca Potestio, Matteo Megna, Alessia Villani, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3323-3331
Open Access | Times Cited: 6
Luca Potestio, Matteo Megna, Alessia Villani, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3323-3331
Open Access | Times Cited: 6
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
Jonathan Kay, Raymond K. Cross, Steven R. Feldman, et al.
Advances in Therapy (2023) Vol. 41, Iss. 2, pp. 509-533
Open Access | Times Cited: 6
Jonathan Kay, Raymond K. Cross, Steven R. Feldman, et al.
Advances in Therapy (2023) Vol. 41, Iss. 2, pp. 509-533
Open Access | Times Cited: 6
A discrete-choice experiment to elicit the treatment preferences of patients with hidradenitis suppurativa in the United States
D. Willems, Christopher Sayed, Hessel H. van der Zee, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 503-508
Open Access | Times Cited: 5
D. Willems, Christopher Sayed, Hessel H. van der Zee, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 503-508
Open Access | Times Cited: 5
Adalimumab-Induced Paradoxical Psoriasis Treated with Biologics Targeting the IL-17/IL-23 Axis in Patients with Hidradenitis Suppurativa
Aikaterini Tsiogka, Aikaterini I. Liakou, Efthimia Agiasofitou, et al.
Dermatology (2023) Vol. 239, Iss. 6, pp. 937-941
Closed Access | Times Cited: 4
Aikaterini Tsiogka, Aikaterini I. Liakou, Efthimia Agiasofitou, et al.
Dermatology (2023) Vol. 239, Iss. 6, pp. 937-941
Closed Access | Times Cited: 4
